Impact of pulmonary hypertension on the course of a late postoperative period after surgical correction of mitral valvular diseases
https://doi.org/10.18705/1607-419X-2005-11-4-271-274
Abstract
Late outcomes were analyzed in 67 patients with pulmonary hypertension, who had undergone surgical correction of acquired mitral valvular diseases in the period sofs months to 11 years (mean 4.6 years). In the late postoperative period, there was no significant difference in the survival rates, in the incidence of high functional class heart failure, and the quality of life in patients with mitral valvular diseases in the presence of pulmonary hypertension and in a normal pulmonary pressure.
About the Authors
Ye. V. Nemchenko
ФГУ НИИ кардиологии им. В.А. Алмазова Росгосздрава
Russian Federation
Russian Federation
S. I. Stepanov
ФГУ НИИ кардиологии им. В.А. Алмазова Росгосздрава
Russian Federation
Russian Federation
References
1. Cesnjevar R.A., Feyrer R., Walther F. et al. High-risk- mitral valve replacement in severe pulmonary hypertension-30 years experience. Kur J Cardiothorac Surg 1998; 13 (4); 344-51.
2. Erdil N., Cetin L., Nisanoglu V. et al. Clinical experience with Sorin Bicarbon valve in patients with tightl mitral valve stenosis and elevated pulmonary hypertension (early and midterm results). J Cardiovasc Surg (Torino) 2002; 43 (4): 423-7.
3. Li M., Donnesnil J.G., Mathieu P., Piharot P. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol 2005; 45 (7): 1034-40.
4. Lorusso R., Borghetti V., Tolaro P. et al. The double-office techniqueor mitral valve reconstruction; predictors of postoperative outcome. Eur J Cardiothorac Surg 2001: 20 (3): 583-9.
5. Rawczynska-Englert I., Korewicki J., Purzycki Z. et al. Analysis of remission pulmonary hypertension after mitral valve replacement. Przegl Lek 1992: 49 (9): 302-5.
6. Сердечно-сосудистая хирургия. Под ред. В.М. Бураковского, Л.А. Бокерия М., 1996.
7. Kerhanl F., Rondelet В., Collart F. el al. Pulmonary arterial hypertension in intensive care unit and operating room. Ann Fr Anesth Reanim 2005; 24 (5); 528-40.
8. Salzberg S.P., Fulsoufl F., Anyanwu A. et al. High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg 2005; 80 (2): 502-6.
9. Ware J.E., Shubouene C.D. The Mos 36-item abort-Farm Health Surrey (SF-36). Conceptual framework and item selection. Medical Care 1992; 30 (6): 473-83.
10. Чучалин А.Г., Белевский А.С., Смоленов И.В. Качество жизни больных бронхиальной астмой в России: результаты многоцентрового популяционного исследования. Пульмонология. 2003: 13 (5): 88-96.
Review
For citations:
Nemchenko Ye.V., Stepanov S.I. Impact of pulmonary hypertension on the course of a late postoperative period after surgical correction of mitral valvular diseases. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2005;11(4):271-274. (In Russ.) https://doi.org/10.18705/1607-419X-2005-11-4-271-274
Views:
963
Email this article 